key: cord-0264845-ncijw27v
authors: Yang, Andrew C.; Vest, Ryan T.; Kern, Fabian; Lee, Davis P.; Maat, Christina A.; Losada, Patricia M.; Chen, Michelle B.; Agam, Maayan; Schaum, Nicholas; Khoury, Nathalie; Calcuttawala, Kruti; Pálovics, Róbert; Shin, Andrew; Wang, Elizabeth Y.; Luo, Jian; Gate, David; Siegenthaler, Julie A.; McNerney, M. Windy; Keller, Andreas; Wyss-Coray, Tony
title: A human brain vascular atlas reveals diverse cell mediators of Alzheimer’s disease risk
date: 2021-04-27
journal: bioRxiv
DOI: 10.1101/2021.04.26.441262
sha: 3cacaf6bd64e15bb4be1a4c8fa23714e88b35988
doc_id: 264845
cord_uid: ncijw27v

The human brain vasculature is of vast medical importance: its dysfunction causes disability and death, and the specialized structure it forms—the blood-brain barrier—impedes treatment of nearly all brain disorders. Yet, no molecular atlas of the human brain vasculature exists. Here, we develop Vessel Isolation and Nuclei Extraction for Sequencing (VINE-seq) to profile the major human brain vascular and perivascular cell types through 143,793 single-nucleus transcriptomes from 25 hippocampus and cortex samples of 17 control and Alzheimer’s disease (AD) patients. We identify brain region-enriched pathways and genes divergent between humans and mice, including those involved in disease. We describe the principles of human arteriovenous organization, recapitulating a gradual endothelial and punctuated mural cell continuum; but discover that many zonation and cell-type markers differ between species. We discover two subtypes of human pericytes, marked by solute transport and extracellular matrix (ECM) organization; and define perivascular versus meningeal fibroblast specialization. In AD, we observe a selective vulnerability of ECM-maintaining pericytes and gene expression patterns implicating dysregulated blood flow. With an expanded survey of brain cell types, we find that 30 of the top 45 AD GWAS genes are expressed in the human brain vasculature, confirmed in situ. Vascular GWAS genes map to endothelial protein transport, adaptive immune, and ECM pathways. Many are microglia-specific in mice, suggesting an evolutionary transfer of AD risk to human vascular cells. Our work unravels the molecular basis of the human brain vasculature, informing our understanding of overall brain health, disease, and therapy.

). Fibroblast or fibroblast-derived protein localization in capillaries 229 poses interesting questions for vessel development and maintenance. As in endothelial and 230 mural cells, perivascular fibroblast-like cell markers varied by species (Fig. 3j) . Together, these 231 data provide a first characterization of human brain fibroblast diversity, revealing the molecular 232 basis of their anatomical specialization and a cooperative circuit for CSF solute exchange.

Vascular cell-type specific perturbations in Alzheimer's disease 235 Alzheimer's disease (AD) is a progressive neurodegenerative disorder culminating in 236 severe impairment of memory, cognition, and executive functions 97, 98 . These impairments arise 237 from complex perturbations in cell composition and gene expression [99] [100] [101] . We thus sought to 238 profile changes in the AD human brain vasculature at single-cell resolution. We defined our AD 239 patient group by clinical diagnosis and confirmed via immunohistochemistry the presence of β-240 amyloid plaques in the hippocampus and cortex (Supplemental Fig. 13 ).

Recent studies have identified context-dependent, disease associated glial 242 subpopulations [28] [29] [30] 67, 102 . We did not observe new vascular cell subclusters emerging with AD 243 (Fig. 4a, Supplemental Fig. 8 ). However, in contrast to parenchymal cells 28, 29 , we found a strong 244 loss of brain vascular nuclei-across endothelial, SMC, pericyte, and fibroblast-like cells-with 245 AD (Fig. 4a-b) . This is consistent with reports of focal cerebrovascular damage in AD 27, 103 , but 246 suggests that vascular loss is widespread across cells types throughout the arteriovenous axis. 247 Interestingly, among pericytes, only M-pericytes involved in ECM organization declined (Fig. 248 4b). This selective, disease-associated susceptibility provides a molecular hypothesis for the 249 physical BBB breakdown and vascular ECM disruption reported in AD 104 . Finally, because the 250 observed reductions in vascular nuclei could also reflect an increased fragility during isolation, 251 we stained for and confirmed our findings in situ (Fig. 4c ). In short, instead of a new AD-252 associated subpopulation emerging, we find in the vasculature an AD-associated 253 disappearance of specific cell type subpopulations. 254 We next systematically examined cell type-specific gene expression changes in AD 255 (Methods). Across the vascular cell types captured in sufficient numbers for statistical power, we 256 identified 463 unique differentially expressed genes using more stringent thresholds (DEGs, 257 Methods, Fig. 4d , Supplemental Table 6 ). Overall, mural cells exhibited the strongest changes, Table 6 ). The vast majority of DEGs were cell type- (Fig. 4e-f ) and zonation-261 specific, suggesting a heterogenous response to AD pathology across the vasculature.

Intriguingly, several DEGs are risk genes implicated in recent AD and small vessel disease GWAS studies (Fig. 4f) . At the pathway level, DEGs in mural cells and fibroblast-like cells 264 implicated dysregulated vasoconstriction and compromised blood flow (Fig. 4g ). This provides a 265 molecular basis for the cerebral hypoperfusion discernible in MRI-based imaging of living AD 266 patients 105, 106 . Interestingly, DEGs in pericytes and SMCs resembled those found in CADASIL 267 and CARASIL [107] [108] [109] [110] (Fig. 4h) , rare hereditary diseases also marked by impaired blood flow, 268 cognitive deficits, repeated strokes, and dementia. 269 APOE4 carriers have been reported to exhibit accelerated BBB breakdown before Table 7 ). Finally, we sought to understand the overlap between human vascular AD DEGs and 274 those in mouse models of AD. Such models have facilitated mechanistic study of β-amyloid 275 pathology, but recent reports describe significant species differences in various cell types, such 276 as microglia 30, 44, 102 . We isolated brain endothelial cells from 12-14 month old Thy1-hAPP Lon,Swe 277 mice (and littermate wild-type controls) 112 that present prominent amyloidosis, 278 neuroinflammation, and synapto-dendritic degeneration-and processed them for single-cell 279 sequencing. Surprisingly, we observed minimal overlap between human AD and mouse hAPP 280 DEGs in brain endothelial cells (Fig. 4j) .

AD pathology begins and spreads via a strikingly consistent regional pattern 98, 113 . We 282 thus assessed the impact of AD on brain regional vascular specialization (Fig. 1e) . Within 283 controls, we found greater vascular density in the cortex compared to hippocampus (Fig. 4k) , 284 reflecting either regional baseline differences or hippocampal deficits with normal aging 114 . We 285 found these regional differences erased in AD patients (Fig. 4k) . Likewise, by comparing the 286 number of DEGs between the cortex and hippocampus of the same patients, we noticed a 287 global loss of brain regional specialization across vascular cell types in AD patients (Fig. 4l )-288 suggesting impairments in brain region-specific vascular function. Together, these findings show 289 that AD patients exhibit heterogeneous cell type-, zonation-, region-, and species-specific 290 perturbations across the brain vasculature that require dedicated isolation and single-cell 291 approaches to profile. 292 293 AD GWAS disease variants enriched in the human brain vasculature 294 A major goal of biomedical research is to identify genes that cause or contribute to 295 disease. GWAs studies have shed insight into the molecular pathways contributing to AD 115, 116 , though the cell type context in which GWAS genes are expressed was long unknown. Recent 297 snRNA-seq and other cell type-resolved studies have strongly implicated microglia as the major 298 AD GWAS-expressing cell type [28] [29] [30] 64, [116] [117] [118] [119] [120] [121] . We wondered, however, whether the unintended 299 depletion of brain vascular cells in conventional preparations may have prematurely dismissed 300 such evidence in brain vascular cells. We curated recent AD GWAS studies [117] [118] [119] 122, 123 to 301 identify and order the top 45 risk genes. With our more comprehensive survey of brain cell 302 types, we calculated the cell type proportional expression for each GWAS gene using 303 Expression Weighted Cell Type Enrichment (EWCE) 124 . We indeed observed among brain 304 parenchymal cells a specific myeloid signature for top AD GWAS genes such as TREM2, 305 MS4A6A, CR1, and SPI1 that are now the subject of intense mechanistic study (Fig. 5a, right) . 306 Intriguingly, we noticed that several GWAS genes were strongly expressed in human 307 brain vascular and perivascular cell types (Fig. 5a , left, Supplemental Fig. 15 ). This included the 308 two GWAS genes previously implicated in the mouse vasculature, PICALM and CD2AP 64,122 .

But this also included other surprising genes, such as the immune-related PLCG2 and HLA-310 DRB1/5 in arterial cells, the endocytic INPP5D and USP6NL in capillaries, and ECM-related 311 ADAMTS1, ADAMTS4, FERMT2, and AGRN in SMCs and pericytes (Fig. 5a ). Within pericytes, 312 expression varied across M-and T-pericyte subtypes (Supplemental Fig. 16a) . APOE, often 313 linked to myeloid cells and astrocytes, was robustly expressed in human SMCs and meningeal 314 fibroblasts. Remarkably, several GWAS genes like ABCA7 and CLNK were enriched in 315 perivascular T cells. Consistent with our findings, an independent dataset shows minimal 316 expression of these genes in parenchymal brain cell types (Supplemental Fig. 16b ). Likewise, 317 several GWAS genes like ABCA1, FHL2, HESX1, and IL34 were enriched in perivascular and 318 meningeal fibroblasts. Importantly, we confirmed our findings via immunohistochemical staining. 319 We observed vascular localization for 12 proteins encoded by predicted-vascular GWAS genes, 320 such as CASS4, FERMT2, ACE, PLCG2, and FHL2 (Fig. 5b) . Most GWAS genes exhibited 321 minor expression differences between the hippocampus and cortex (Supplemental Fig. 16c ). In The human brain vascular expression of putatively parenchymal-especially myeloid-327 AD GWAS genes made us wonder whether these genes are expressed in different cell types 328 between mice and humans. We thus examined the expression of human vascular GWAS genes 329 in mouse datasets 90 . Indeed, many genes like APOE, CASS4, INPP5D, and HLA-DRB1 were predominately expressed in microglia in mice but then also exhibited vascular expression in 331 humans (Fig. 5c, Supplemental Fig. 16d ). Corroborating this, nearly every top GWAS gene 332 expressed in BECs exhibited greater expression in humans than in mice (Fig. 5c ). Together, 333 these data suggest a partial evolutionary transfer of AD risk genes and pathways from microglia 334 to the vasculature from mice to humans, with implications for translational studies. 335 We next broadened our scope to a previously compiled list of hundreds of GWAS genes 336 for AD and AD-related traits (Supplemental Fig. 17a-b) 29 . We observed robust expression 337 across vascular and perivascular cell types (Supplemental Fig. 17a-b) . Using EWCE analysis, 338 we found that many risk genes were expressed cell type-specifically (Supplemental Fig. 17 ). For 339 each gene, we assigned the cell type with the strongest expression, discovering surprisingly, 340 that endothelial cells harbored the most AD-related GWAS genes, followed by microglia/ 

We report here 143,793 single-cell, genome-wide quantitative transcriptomes from the 357 human brain vasculature in health and AD. We use these transcriptomes to molecularly define 358 the principal vascular cell types; their differences by brain region and species; the organizational 359 principles of endothelial, mural, and fibroblast-like cells; a selective loss of M-pericytes and the 360 transcriptomic perturbations contributing to clinical AD dementia; and the unexpected 361 expression of AD GWAS genes across the human brain vasculature. We subsequently confirm 362 these findings in situ at the protein level. Single-cell resolution was necessary for these findings, 363 which would have been obscured in the average profiles generated via bulk RNA-sequencing. How do human vascular GWAS genes fit into established AD pathways? Current understanding implicates β-amyloid metabolism, cholesterol/ lipid dysfunction, innate immunity, 366 and endocytosis 121, 125 . Vascular GWAS gene expression confirms these pathways and expands 367 the set of cell types involved, such as β-amyloid endocytosis and clearance via BEC clathrin-368 mediated transport; and adaptive in addition to innate immunity via perivascular T cells (Fig. 5f ). 369 We propose that the dramatic expansion of the human brain, brain activity, and activity Given the evolutionary divergence between mice and humans, these data expand by 385 orders of magnitude the number of arteriovenous markers in the human brain that can now be 386 used for vessel type identification, to assess the fidelity of in vitro human cell and organoid 387 cultures, and to reliably deconvolute and enhance the utility of hundreds of publicly available 388 bulk brain RNA-seq datasets (Supplemental Table 2 ). Mechanistic studies in mouse models can 389 now be combined with this dataset to systematically pinpoint the cell types and genes mediating Our work opens several translational opportunities. This dataset informs ongoing efforts 398 to develop 'brain shuttles' and other modalities to better deliver therapeutics to treat human 399 brain disorders 15, 21 . This method facilitates study of the brain vasculature across a variety of 400 disease conditions, such as stroke, multiple sclerosis, and even COVID-19 67 . Together, the field 401 now has a near complete catalog of cell types in the human brain, which can be integrated into 402 ongoing efforts such as the Human Cell Atlas 138 . As with recent high-profile snRNA-seq studies 403 of the brain parenchyma [28] [29] [30] [31] [32] 139 , it will now be important to distinguish which of the vascular c, Immunohistochemical validation of cell type-specific gene markers from (b) for brain endothelial cells (BECs), pericytes, and perivascular fibroblast-like cells. Arrowhead (middle) identifies staining of thinstrand pericyte morphology. C (right) indicates capillary staining. Scale bar = 50 microns. Images from the Human Protein Atlas (http://www.proteinatlas.org) 75, 140 .

d, Distribution of cell populations, identified from nuclei isolated from the hippocampus and frontal superior cortex, after sub-clustering analysis. Color code corresponds to (b). e, Enriched biological pathways in BECs from the hippocampus compared to the superior frontal cortex, and vice versa, in control patient samples.

f, Scatter plot depicting mRNA expression levels (logCPM) of mouse and human genes with one-to-one orthologs in BECs (left) and pericytes (right), highlighting significantly differentially expressed genes in human (blue) and mouse microglia (green) (>10-fold difference, minimum 0.5 log2CPM expression).

g, Immunohistochemical validation of A2M protein localized specifically in the human but not mouse vasculature. Scale bar = 50 microns. Venous specificity score = avg(logFC(vein/cap), logFC(vein/art)). For example, VWF is predicted to be more specific to venous BECs in mice than it is in humans. See Supplemental Figure 9 for arterial and capillary specificity plots. e, Immunohistochemical validation of VWF specificity to venous BECs in mice but not in humans. Comparison of VWF gene expression in mice and human BECs (top) and corresponding VWF protein staining (bottom). Scale bar = 50 microns.

f, UMAP of 34,508 human pericyte and smooth muscle cell nuclei, colored by cell subtype. Enriched biological pathways from directly comparing amongst the pericyte and SMC populations. aSMC = arterial smooth muscle cell (aSMC), aaSMC = arteriole SMCs, T-Pericyte = solute transport pericytes, and M-Pericyte = Extracellular matrix regulating pericytes.

g, As in (c) but for pericytes and smooth muscle cells. Solid line delineating aaSMC/aSMCs from pericytes reflects an abrupt transcriptomic transition.

h, Immunohistochemical localization of T-and M-pericyte markers in both large and small diameter vessels, suggesting pericyte subtypes do not represent a pericyte-vSMC split. Scale bar = 50 microns. Images from the Human Protein Atlas (http://www.proteinatlas.org) 75, 140 .

i, Overlap between the top 100 human endothelial and mural cell subtype markers and those identified in mice. A more lenient set of 500 (instead of 100) mouse markers 37 were used for comparison to ensure claims of species-specificity were robust.

Note: the species-conservation of a cell type marker depends on species-specific changes in the given cell type and changes amongst the remaining background cell types. Table 2 ). c, Expression of example markers demarcating perivascular from meningeal fibroblasts. h, Expression of perivascular fibroblast-like cell-specific markers CYP1B1 and ABCA8 compared to all other CNS cell types (top). Immunohistochemical co-localization (bottom) of CYP1B1 and ABCA8 to small diameter (< 10 microns, black brackets, 'C') capillaries in the human brain. Scale bar = 50 microns.

i, Overlap between the top 100 perivascular fibroblast-like cell markers and those identified in mice. A more lenient set of 500 (instead of 100) mouse markers 37 were used for comparison to ensure claims of species-specificity were robust.

Note: the species-conservation of a cell type marker depends on species-specific changes in the given cell type and changes amongst the remaining background cell types. j, Venn diagram comparing DEG BECs in human AD samples compared to those from the Thy1-hAPP T41B Lon,Swe amyloidosis mouse model 112 . Note that only genes with human-mouse orthologs are shown, and that the absolute logFC threshold for calling DEGs in mouse APP BECs was lowered to 0.15 (by half) to ensure claims of limited overlap with human BECs were robust. k, Among patients with both hippocampus and superior frontal cortex profiled (n=4 controls and n=4 AD), quantification of the relative abundance of major vascular cell types (control hippocampus set as reference, unpaired two-sided t-test; mean +/-s.e.m.). l, As in (k), but comparison of the number of DEGs between brain regions for each cerebrovascular cell type. Analysis done separately for control and AD samples (n=7 cell types, unpaired two-sided t-test; mean +/-s.e.m.) e, Human enrichment of AD-related trait GWAS genes 29 highest expressed in BECs (left) and mural cells (right). In contrast to GWAS genes, the ratio of human to mouse expression across the whole transcriptome is less than or ~1 for both cell types (bottom, paired two-sided t-test, ****P < 0.0001 and ***P = 0.0002).

f, Summary of AD GWAS genes enriched in microglia and vascular cells mediating common pathways in protein clearance and inflammation. Mouse and human superscripts denote whether expression has been confirmed in that species for a given gene. Proposed model is described in Discussion. 

Post-mortem fresh-frozen hippocampus and superior frontal cortex tissue were obtained from the Stanford/ VA/ NIA Aging Clinical Research Center (ACRC) with approval from local ethics committees and patient consent. Group characteristics are presented in Supplemental Table 1 . Note, patients were grouped by clinical diagnosis, with two of the control patients exhibiting amyloid beta plaque staining in the hippocampus, though not to a sufficient degree for an expert pathologist to diagnose Alzheimer's disease by histopathological criteria. Clinical instead of pathologic diagnosis was chosen because of potentially vascular contributions to AD independent of the well-known hallmarks of AD, β-amyloid and tau pathophysiology 7 . All procedures were carried out on ice in a 4°C cold room as rapidly as possible. 0.3 grams or more of brain tissue was thawed on ice for 5 minutes with 5 ml of nuclei buffer (NB): 1% BSA containing 0.2 U μl −1 RNase inhibitor (Takara, 2313A) and EDTA-free Protease Inhibitor Cocktail (Roche, 11873580001). Tissue was quickly minced and homogenized with 7 ml glass douncers (357424, Wheaton) until no visible chunks of debris remained. Similar to before 54 , homogenates were transferred into 50 ml tubes containing 35 ml of chilled 32% dextran (D8821, Sigma) in HBSS. Samples were vigorously mixed before centrifugation at 4,400g for 20 minutes with no brake. After centrifugation, samples separate into a top myelin layer, middle parenchymal layer, and vascular-enriched pellet. The myelin layer was aspirated, tips changed, and the parenchymal layer carefully removed without disturbing the pellet. Pellets were resuspended in 8 ml of 32% dextran, transferred to 15 ml falcon tubes, and centrifuged again. Vascularenriched pellets were gently resuspended in 1ml of NB and added to pre-wetted 40 μm strainer sitting atop 50 ml falcon tubes. From here diverging from prior protocol, strainers were washed with 10 ml of cold 0.32 M sucrose in PBS and 90 ml of PBS until flow through the strainers was unimpeded to deplete contaminating parenchymal cells from trapped microvessels. At this step, retained microvessels turn white in color, indicating removal of circulating blood cells. Strainers were switched to new collection 50 ml falcon tubes. Various techniques were tested and optimized to extract vascular cells from the isolated microvessels (e.g., enzymatic digestion, TisssueRuptor, sonication, etc.), but nearly all resulted in loss of nuclei integrity or low nuclei complexity (<50 median genes/ nuclei). Eventually, adapting a method for the isolation of murine splenocytes proved successful: vascular fragments were mashed four times through the cell strainer using the plunger end of a 3 ml syringe, with intermittent elution via 10 ml of 0.32 sucrose and 40 ml of PBS. Liberated vascular cells were pelleted at 500g for 10 minutes and resuspended in 1.5 ml of EZ Prep Lysis Buffer (Sigma, NUC101) spiked with 0.2 U μl −1 RNase inhibitor (Takara, 2313A) and EDTA-free Protease Inhibitor Cocktail (Roche, 11873580001). Nuclei were homogenized with 2 ml glass douncers (D8938, Sigma) 20 times with pestle B (pestle A optional). Spiked EZ lysis buffer was added to samples up to 4 ml and incubated on ice for 5 minutes before pelleting at 500g for 6 minutes. This incubation step was repeated. Debris was depleted via a sucrose gradient before flow cytometry isolation of nuclei. Briefly, pelleted nuclei were resuspended in 0.5ml of NB before the addition of 0.9 ml of 2.2 M sucrose in PBS. This mixture was layered atop 0.5 ml of 2.2 M and samples were centrifuged at 14,000g for 45 minutes at 4°C, with no brake. Pellets were aspirated in 1ml of NB, filtered through a 40 μm strainer (Flowmi), transferred to FACS tubes, stained with Hoechst 3342 (1:2000, Thermo) and rabbit monoclonal anti-NeuN Alexa Fluor® 647 (1:500, Abcam, ab190565), and nuclei collected on a SH800S Cell Sorter into chilled tubes containing 1 ml of NB without protease inhibitor. In pilot runs, we noticed the cytometer overestimated nuclei counts by ~3.4x, and thus we sorted ~34,000 nuclei to target ~10,000 nuclei per sample. Sorted samples were inspected for lack of debris on a brightfield microscope. We note that an iodixanol gradient 52 can substitute for the 2.2 M sucrose, but that unfortunately with either gradient, flow sorting is required-unlike parenchymal myelin debris, vascular debris is not sufficiently removed by gradient centrifugation alone. Vascular debris will confound downstream cDNA traces with higher background and low molecular weight peaks. We are happy to share the detailed protocol widely but note that since high-quality human postmortem brain tissue is difficult to obtain, tissue would be limited in quantities to share widely.

For droplet-based snRNA-seq, libraries were prepared using the Chromium Single Cell 3ʹ v3 according to the manufacturer's protocol (10x Genomics), targeting 10,000 nuclei per sample after flow sorting (Sony SH800S Cell Sorter). 15 PCR cycles were applied to generate cDNA before 16 cycles for final library generation. Generated snRNA-seq libraries were sequenced on S4 lanes of a NovaSeq 6000 (150 cycles, Novogene) .

snRNA-seq quality control Gene counts were obtained by aligning reads to the hg38 genome (refdata-gex-GRCh38-2020-A) using CellRanger software (v.4.0.0) (10x Genomics). To account for unspliced nuclear transcripts, reads mapping to pre-mRNA were counted. As previously published, a cut-off value of 200 unique molecular identifiers (UMIs) was used to select single nuclei for further analysis 28 . As initial reference, the entire dataset was projected onto two-dimensional space using Uniform Manifold Approximation and Projection (UMAP) on the top 30 principal components 142 . Three approaches were combined for strict quality control: (1) outliers with a high ratio of mitochondrial (>5%, <200 features) relative to endogenous RNAs and homotypic doublets (> 5000 features) were removed in Seurat 143 ; (2) after scTransform normalization and integration, doublets and multiplets were filtered out using DoubletFinder 144 ; and (3) after DoubletFinder, nuclei were manually inspected using known cell type-specific marker genes, with nuclei expressing more than one cell type-specific marker further filtered 144 . For example, BEC nuclei containing any reads for the following cell type markers were subsequently filtered: MOBP, MBP, MOG, SLC38A11, LAMA2, PDGFRB, GFAP, SLC1A2, and AQP4. We note that the vascular nuclei in prior human single cell datasets exhibit contamination with other cell type-specific gene markers, potentially confounding downstream analysis. After applying these filtering steps, the dataset contained 143,793 high-quality, single nuclei.

Seurat's Integration function was used to align data with default settings. Genes were projected into principal component (PC) space using the principal component analysis (RunPCA). The first 30 dimensions were used as inputs into Seurat's FindNeighbors, FindClusters (at 0.2 resolution) and RunUMAP functions. Briefly, a shared-nearest-neighbor graph was constructed based on the Euclidean distance metric in PC space, and cells were clustered using the Louvain method. RunUMAP functions with default settings was used to calculate 2-dimensional UMAP coordinates and search for distinct cell populations. Positive differential expression of each cluster against all other clusters (MAST) was used to identify marker genes for each cluster 145 . We annotated cell-types using previously published marker genes 28, 30, 32, 146 . For brain endothelial cells, zonation specificity scores for each gene were calculated separately for arterial, capillary, and venous segments as in the following example for a given gene in capillaries:

Differential gene expression of genes comparing Alzheimer's disease, ApoE4, and control samples-or comparing cell type sub-cluster markers-was done using the MAST 145 algorithm, which implements a two-part hurdle model. Seurat natural log (fold change) > 0.5 (absolute value), adjusted P value (Bonferroni correction) < 0.01, and expression in greater than 10% of cells in both comparison groups were required to consider a gene differentially expressed for subcluster analysis and natural log (fold change) > 0.3 (absolute value), adjusted P value (Bonferroni correction) < 0.01, and expression in greater than 10% of cells in both comparison groups for Alzheimer's disease and ApoE4 comparisons, both more stringent than the default Seurat settings. We incorporated age, gender, and batch as covariates in our model. A more lenient threshold of the above but with natural log (fold change) > 0.2 (absolute value) was used for brain region (i.e., hippocampus vs cortex. Biological pathway and gene ontology enrichment analysis was performed using Enrichr 147 or Metascape 141 with input species set to Homo sapiens 141 . UpSet plots were generated using identified differentially expressed genes as inputs using the R package UpSetR 148 . Diagrams were created with BioRender.

Monocle was used to generate the pseudotime trajectory analysis in brain endothelial and mural cells 74 . Cells were clustered in Seurat and cluster markers used as input into Monocle to infer arteriovenous relationships within endothelial cells and pericytes. Specifically, UMAP embeddings and cell sub-clusters generated from Seurat were converted to a cell_data_set object using SeuratWrappers (v.0.2.0) and then used as input to perform trajectory graph learning and pseudo-time measurement through Independent Component Analysis (ICA) with Monocle. Cluster marker genes identified in Seurat were used to generate a pseudotime route and plotted using the 'plot_pseudotime_heatmap' function.

Cell-cell interactions based on the expression of known ligand-receptor pairs in different cell types were inferred using CellChatDB 93 (v.0.02). Briefly, we followed the official workflow and loaded the normalized counts into CellChat and applied the preprocessing functions identifyOverExpressedGenes, identifyOverExpressedInteractions, and projectData with standard parameters set. As database we selected the Secreted Signaling pathways and used the pre-compiled human Protein-Protein-Interactions as a priori network information. For the main analyses the core functions computeCommunProb, computeCommunProbPathway, and aggregateNet were applied using standard parameters and fixed randomization seeds. Finally, to determine the senders and receivers in the network the function netAnalysis_signalingRole was applied on the netP data slot.

Whole cell isolation from the CNS followed previously described methods 20, 40, 58 . Briefly, cortices and hippocampi were microdissected, minced, and digested using the Neural Dissociation Kit (Miltenyi). Suspensions were filtered through a 100 µm strainer and myelin removed by centrifugation in 0.9 M sucrose. The remaining myelin-depleted cell suspension was blocked for ten minutes with Fc preblock (CD16/ CD32, BD 553141) on ice and stained for 20 minutes with antibodies to distinguish brain endothelial cells (CD31 + / CD45 -). Brain endothelial cells from 12-14 month old Thy1-hAPP Lon,Swe mice and littermate wild-type control 112 mice (pool of 4-6 mice per group) were sorted into PBS with 0.1% BSA. Nuclei isolation from 4-6 month-old mouse hippocampi followed protocols adapted from previous studies [28] [29] [30] 52, 149 . Briefly, tissue was homogenized using a glass douncer in 2 ml of ice-cold EZ PREP buffer (Sigma, N3408) and incubated on ice for 5 min. Centrifuged nuclei were resuspended in 1% BSA in PBS with 0.2 U μl −1 RNase inhibitor and filtered through a 40 μm cell strainer. Cells or nuclei were immediately counted using a Neubauer haemocytometer and loaded on a Chromium Single-Cell Instrument (10x Genomics, Pleasanton, CA, USA) to generate single-cell GEMs. The 10x-Genomics v3 libraries were prepared as per the manufacturer's instructions. Libraries were sequenced on an Illumina NextSeq 550 (paired-end; read 1: 28 cycles; i7 index: 8 cycles, i5 index: 0 cycles; read 2: 91 cycles). De-multiplexing was performed using the Cellranger toolkit (v3.0.0) "cellranger mkfastq" command and the "cellranger count" command for alignment to the mouse transcriptome, cell barcode partitioning, collapsing unique-molecular identifier (UMI) to transcripts, and gene-level quantification. ~70% sequencing saturation (>20,000 reads per cell) was achieved, for a median of ~2,000 genes detected per cell and ~16,500 genes detected in total. Downstream analysis using the Seurat package (v3) 150 was performed as previously described 37 , applying standard algorithms for cell filtration, feature selection, and dimensionality reduction. Samples with fewer than 1,000 and more than 4,000 unique feature counts, samples with more than 15% mitochondrial RNA, samples with more than 15% small subunit ribosomal genes (Rps), and counts of more than 10,000 were excluded from the analysis. Genes were projected into principal component (PC) space using the principal component analysis (RunPCA). The first 30 dimensions were used as inputs into Seurat's FindNeighbors and RunTsne functions. Briefly, a shared-nearest-neighbor graph was constructed based on the Euclidean distance metric in PC space, and cells were clustered using the Louvain method. RunTsne functions with default settings was used to calculate 2-dimensional tSNE coordinates and search for distinct cell populations. Cells and clusters were then visualized using 3-D tdistributed Stochastic Neighbor embedding on the same distance metric. Differential gene expression analysis was done by applying the Model-based Analysis of Single-cell Transcriptomics (MAST). Significant differentially expressed genes in Thy1-hAPP Lon,Swe BECs were called by Log (fold change) > 0.15 (absolute value), adjusted P value (Bonferroni correction) < 0.01. This lowered Log (fold change) was to ensure our claims of limited overlap with human AD BECs were robust.

For calculation of proportional cell type-specific gene expression, we followed the expression weighted cell type enrichment (EWCE) method described by Skene et al. 124 , and used previously on human snRNA-seq data 29 . For Alzheimer's disease (AD) analysis, we compiled a list of top GWAS risk genes from Lambert et al. 117 , Kunkle et al. 118 , and Jansen et al. 119 , sorted descending by approximate P-value. Each gene's expression sums to 1 across the cell types, with each heatmap cell showing the fraction of total gene expression as determined from EWCE analysis. The set of 720 AD and AD-related trait GWAS genes were obtained from Grubman, et al. 29 , and using EWCE analysis, the strongest expressing cell type was determined for each gene. Note that the original list was slightly parsed to 720, as several genes were not detected as expressed in our dataset.

For analysis across CNS diseases, from the GWAS catalog 151 , we obtained GWAS risk genes for neurological disorders [Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), brain aging, multiple system atrophy (MSA), multiple sclerosis (MS), Parkinson's disease (PD), and narcolepsy], psychiatric disorders [Attention deficit hyperactivity disorder (ADHD), autism, bipolar disorder, depression, psychosis, post-traumatic stress disorder (PTSD), and schizophrenia], and neurobehavior traits [Anxiety, suicidality, insomnia, neuroticism, risk behavior, intelligence, and cognitive function]. We removed gene duplicates and GWAS loci either not reported or in intergenic regions and used a P < 9 × 10 −6 to identify significant associations 29 . Then, since GWAS signals can point to multiple candidate genes within the same locus, we focused on the 'Reported Gene(s)' (genes reported as associated by the authors of each GWAS study). Following gene symbol extraction, we curated the gene set by (1) removing unknown or outdated gene names using the HGNChelper package (v.0.8.6), (2) converting remaining Ensembl gene IDs to actual gene names using the packages ensembldb (v.2.10.0) and EnsDb.Hsapiens.v86 (v.2.99.0), and (3) removing any remaining duplicates. For each disease, we allocated each of its GWAS risk genes to the cell type that proportionally expressed it most (EWCE analysis), before tallying this number in both counts and as a percentage of the diseases total number of GWAS risk genes. Finally, a statistical enrichment of each overlap against background was calculated using a hypergeometric test with the total background size set equal to the number of unique genes (21, 306) .

Fresh-frozen control and AD human brain tissue (hippocampus and superior frontal cortex) adjacent to tissue processed for snRNA-seq was subjected to immunohistochemistry (IHC). 10 µm sections mounted on SuperFrost Plus glass slides were fixed with 4% paraformaldehyde (Electron Microscopy Services, 15714S) diluted in PBS at 4°C for 15 minutes before dehydration via an ethanol series or air drying. Sections were blocked in TBS++ (TBS + 3% donkey serum (130787, Jackson ImmunoResearch) + 0.25% Triton X-100 (T8787, Sigma-Aldrich)) for 1.5 hours at room temperature. Sections were incubated with primary antibodies at 4°C overnight: mouse monoclonal anti-CD31 (1:100, JC70A, Dako), rabbit polyclonal anti-VWF (1:100, GA527, Dako), rabbit polyclonal anti-SLC39A10 (1:100, HPA066087, Atlas Antibodies), rabbit polyclonal anti-ALPL (1:100, HPA007105, Atlas Antibodies), rabbit polyclonal anti-A2M (1:100, HPA002265, Atlas Antibodies), rabbit monoclonal anti-β-Amyloid (1:500, clone D54D2 XP, CST), and mouse monoclonal anti-Actin, α-Smooth Muscle -Cy3 (1:100, clone 1A4, Sigma). Sections were washed, stained with Alexa Fluor-conjugated secondary antibodies (1:250) and Hoechst 33342 (1:2000, H3570, Thermo), mounted and coverslipped with ProLong Gold (Life Technologies) or VECTASHIELD (Vector Laboratories before imaging on a confocal laser scanning microscope (Zeiss LSM880). Age-related autofluorescence was quenched prior to mounting with Sudan Black B, as before 15, 58 . National Institutes of Health ImageJ software was used to quantify the percentage of vasculature (CD31) or the predicted DEG SLC39A10 among CD31+ vasculature, following previously described protocols 15, 152, 153 . All analyses were performed by a blinded observer.

Data Availability. Raw sequencing data is deposited under NCBI GEO: GSE163577. Data is

The Cerebral Circulation, Second Edition

Global and regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease Study

The burden of cerebrovascular disease in the United States

The global burden of stroke: persistent and disabling

Establishment and Dysfunction of the Blood-Brain Barrier

Blood-brain barrier: From physiology to disease and back

The Pathobiology of Vascular Dementia

The blood-brain barrier in health and chronic neurodegenerative disorders

Blood-Brain barrier breakdown in the aging human hippocampus

Alzheimer's disease: A matter of blood-brain barrier dysfunction?

Healthy aging and the blood-brain barrier

The blood-brain barrier in health and disease

The Molecular Constituents of the Blood-Brain Barrier

The blood-brain barrier in health and disease: Important unanswered questions

Physiological blood-brain transport is impaired with age by a shift in transcytosis

Development, maintenance and disruption of the blood-brain barrier

Astrocyte-endothelial interactions at the blood-brain barrier

Drug transport across the blood-brain barrier

Translational aspects of blood-brain barrier transport and central nervous system effects of drugs: from discovery to patients

Discovery of Novel Blood-Brain Barrier Targets to Enhance Brain Uptake of Therapeutic Antibodies

Developing Therapeutic Antibodies for Neurodegenerative Disease

Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys

Pericytes are required for bloodĝ€"brain barrier integrity during embryogenesis

Pericytes regulate the blood-brain barrier

The Evolving Concept of the Blood Brain Barrier (BBB): From a Single Static Barrier to a Heterogeneous and Dynamic Relay Center

Heterogeneity of the bloodbrain barrier

The role of brain vasculature in neurodegenerative disorders

Single-cell transcriptomic analysis of Alzheimer's disease

A single-cell atlas of entorhinal cortex from individuals with Alzheimer's disease reveals cell-type-specific gene expression regulation

Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease

Altered human oligodendrocyte heterogeneity in multiple sclerosis

Single-cell genomics identifies cell type-specific molecular changes in autism

Single-nucleus RNA-seq identifies Huntington disease astrocyte states

Cell densities in the mouse brain: A systematic review

Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia

Increased brain size and glial cell number in CD81-null mice

A molecular atlas of cell types and zonation in the brain vasculature

Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells

Single-Cell Transcriptome Atlas of Murine Endothelial Cells

Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris

Brain endothelial cells are exquisite sensors of age-related circulatory cues

Molecular Diversity and Specializations among the Cells of the Adult Mouse Brain

Estimation of divergence times from multiprotein sequences for a few mammalian species and several distantly related organisms

Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program

Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids

Ly6a Differential Expression in Blood-Brain Barrier Is Responsible for Strain Specific Central Nervous System Transduction Profile of AAV-PHP.B. Hum

The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier

Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer's and Parkinson's diseases

Massively parallel single-nucleus RNA-seq with DroNc-seq

Cells of the adult human heart

Molecular characterization of selectively vulnerable neurons in Alzheimer's disease

An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues

Capillary Depletion Method for Quantification of Blood-Brain Barrier Transport of Circulating Peptides and Plasma Proteins

A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus

Single-cell analysis reveals T cell infiltration in old neurogenic niches

Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1

Β2-Microglobulin Is a Systemic Pro-Aging Factor That Impairs Cognitive Function and Neurogenesis

Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse

Complement C3 deficiency leads to accelerated amyloid β plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice

α2-macroglobulin associates with β-amyloid peptide and prevents fibril formation

Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer's disease

Alzheimer's disease risk genes and mechanisms of disease pathogenesis

The betaine/GABA transporter and betaine: Roles in brain, kidney, and liver

Effects of COVID-19 on the Nervous System

Broad transcriptional dysregulation of brain and choroid plexus cell types with

Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies

Altered perivascular fibroblast activity precedes ALS disease onset

Single-cell spatial reconstruction reveals global division of labour in the mammalian liver

Analysis of the brain mural cell transcriptome

The cortical angiome: An interconnected vascular network with noncolumnar patterns of blood flow

Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells

The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells

Tissue-based map of the human proteome

Von Willebrand factor: An emerging target in stroke therapy

Von Willebrand factor in CHD and stroke: Relationships and therapeutic implications

Do stroke models model stroke?

Animal models of ischemic stroke and their application in clinical research

Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain?

Type IV Collagens and Basement Membrane Diseases: Cell Biology and Pathogenic Mechanisms

Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq

An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex

A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β

Structural and functional features of central nervous system lymphatic vessels

Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules

Single-Cell Transcriptomic Analyses of the Developing Meninges Reveal Meningeal Fibroblast Diversity and Function

CNS fibroblasts form a fibrotic scar in response to immune cell infiltration

Perivascular fibroblasts form the fibrotic scar after contusive spinal cord injury

Inference and analysis of cell-cell communication using CellChat

CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes

Chronic overproduction of transforming growth factor-β1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice

Alzheimer's disease

Neuropathological stageing of Alzheimer-related changes

The Cellular Phase of Alzheimer's Disease

Neuroinflammation in Alzheimer's disease

Neural mechanisms of ageing and cognitive decline

A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease

Establishment and Dysfunction of the Blood-Brain Barrier

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Cerebral blood flow in Alzheimer's disease. Vasc. Health Risk Manag

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: Initial experience

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

Role of Notch signaling in neurovascular aging and Alzheimer's disease

APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline

Early formation of mature amyloid-β protein deposits in a mutant APP transgenic model depends on levels of Aβ1-42

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Blood-Brain barrier breakdown in the aging human hippocampus

Systematic localization of common disease-associated variation in regulatory DNA

Brain cell type-specific enhancer-promoter interactome maps and disease-risk association

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk

Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk

Genes, pathways and risk prediction in Alzheimer's disease

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

Largest GWAS (N=1,126,563) of Alzheimer's Disease Implicates Microglia and Immune Cells. medRxiv

Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment

Pathways to Alzheimer's disease

Neuronal activity regulates the regional vulnerability to amyloid-β 2 deposition

Age-related myelin degradation burdens the clearance function of microglia during aging

Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model

Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion

Age Mosaicism across Multiple Scales in Adult Tissues

Amyloid b oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes

Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease

Genetic and epigenetic fine mapping of causal autoimmune disease variants

Enhancer evolution across 20 mammalian species

ATAC-seq: A method for assaying chromatin accessibility genome-wide

ChIP-seq: Advantages and challenges of a maturing technology

Mapping of long-range chromatin interactions by proximity ligation-assisted ChIPseq

The human cell atlas

Neuronal vulnerability and multilineage diversity in multiple sclerosis

A subcellular map of the human proteome

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

UMAP: Uniform Manifold Approximation and Projection

Spatial reconstruction of single-cell gene expression data

Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors

MAST: A flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data

Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain

Enrichr: Interactive and collaborative HTML5 gene list enrichment analysis tool

UpSetR: An R package for the visualization of intersecting sets and their properties

In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9

Integrating single-cell transcriptomic data across different conditions, technologies, and species

The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019

Brain Endothelial Cells Are Exquisite Sensors of Age-Related Circulatory Cues

Multiple Click-Selective tRNA Synthetases Expand Mammalian Cell-Specific Proteomics

Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease

Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke

We thank T. Iram